Market Place
Sourcing Support
Juvisé licenses J&J’s MS drug Ponvory for marketing outside North America
27 Mar 2024 //
PHARMACEUTICAL TECHNOLOGY
Juvisé Acquires Multiple Sclerosis Drug PONVORY and also Opens Its Capital
26 Mar 2024 //
BUSINESSWIRE
Juvisé Pharmaceuticals completes €400m refinancing after acquiring Pylera rights
05 Jul 2022 //
PRESS RELEASE
Life Sciences team scoops seven LMG Life Sciences Europe Awards
05 May 2021 //
BUSINESSWIRE
The French speciality pharmaceutical, Juvisé acquires two onco products from AZ
20 Dec 2020 //
PRESS RELEASE
Juvisé Pharmaceuticals: An atypical player in the world of pharmacy
14 Dec 2020 //
BFMTV
Juvisé successfully syndicated its EUR 213 m financing in less than one month
04 Feb 2020 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.